医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
IONS · IONIS PHARMACEUTICALS INC
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
IONIS PHARMACEUTICALS INC（IONS）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 $1.1M、卖出 $3.6M；高管董事有效买入 $1.1M、有效卖出 —。最近申报 2026-10-19。
买入 Bought$1.1M
卖出 Sold$3.6M
有效买入 Effective bought$1.1M
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-16 | Devers Shannon L. EVP, Chief Human Resources Ofc | 卖出 Sell | 1,357 | $43.54 | $59K | SEC |
| 2026-10-16 | Swayze Eric EVP Research | 卖出 Sell | 53 | $43.55 | $2K | SEC |
| 2026-07-30 | Hayden Michael R Director | 买入 Buy · 有效 | 20,000 | $52.94 | $1.1M | SEC |
| 2026-07-07 | BENNETT C FRANK EVP, Chief Scientific Officer | 卖出 Sell | 20,536 | $84.95 | $1.7M | SEC |
| 2026-07-07 | Diaz Allene M. Director | 卖出 Sell | 10,111 | $85.42 | $864K | SEC |
| 2026-07-07 | Kordasiewicz Holly B. EVP, Chief Development Officer | 卖出 Sell | 362 | $84.30 | $31K | SEC |
| 2026-07-01 | KLEIN JOSEPH III Director | 卖出 Sell | 11,518 | $79.04 | $910K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-16 | Devers Shannon L. Officer | 1,357 | $60K | |
| 2026-07-07 | BENNETT C FRANK Officer | 67,386 | $5.7M | 10b5-1 |
| 2026-07-07 | Diaz Allene M. Director | 10,111 | $864K | 10b5-1 |
| 2026-07-07 | Kordasiewicz Holly B. Officer | 1,287 | $108K | 10b5-1 |
| 2026-07-01 | KLEIN JOSEPH III Director | 11,518 | $910K | 10b5-1 |
内部人 Insiders
Devers Shannon L.、Swayze Eric、Hayden Michael R、BENNETT C FRANK、Diaz Allene M.、Kordasiewicz Holly B.、KLEIN JOSEPH III